OKYO Pharma Ltd
NASDAQ:OKYO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OKYO Pharma Ltd
NASDAQ:OKYO
|
UK |
|
C
|
Crown Holdings Inc
F:CWN
|
US |
|
Nitco Ltd
NSE:NITCO
|
IN |
|
Booz Allen Hamilton Holding Corp
NYSE:BAH
|
US |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
Infineon Technologies AG
F:IFX
|
DE |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
|
Cobalt Blue Holdings Ltd
F:COH
|
AU |
|
Teuton Resources Corp
XTSX:TUO
|
CA |
|
N
|
Neuronetics Inc
SWB:NRC
|
US |
|
AUB Group Ltd
ASX:AUB
|
AU |
|
SIG Group AG
F:1YQA
|
CH |
|
UBM Development AG
F:2U2
|
AT |
|
Socialwire Co Ltd
TSE:3929
|
JP |
|
Tectonic Therapeutic Inc
NASDAQ:TECX
|
US |
|
L
|
LY Corp
DUS:YOJ
|
JP |
|
KCC Corp
KRX:002380
|
KR |
|
Ringkjoebing Landbobank A/S
F:CJ2
|
DK |
|
Flowers Foods Inc
NYSE:FLO
|
US |
|
S
|
Shake Shack Inc
SWB:9SH
|
US |
|
F
|
Freshpet Inc
F:7FP
|
US |
|
M
|
Mitsubishi Heavy Industries Ltd
F:MIH
|
JP |
|
Luceco PLC
F:2LC
|
UK |
|
F
|
F4 Uranium Corp
OTC:FFUCF
|
CA |
Bankruptcy Probability
OKYO Pharma Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OKYO Pharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
OKYO Pharma Ltd
NASDAQ:OKYO
|
69.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OKYO Pharma Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OKYO Pharma Ltd has no debt.
You can find a full breakdown on its Balance Sheet.